Enzo loses US probe patent case, seeks new hearing
This article was originally published in Clinica
Diagnostics and healthcare products manufacturer Enzo Biochem has lost its US patent case, in which is was claiming that San Diego-based Gen-Probe's Neisseria gonorrhoeae nucleic acid probe diagnostic infringed its patent. The case, launched by Enzo in 1999, was resolved last week when judges at the US Court of Appeal decided 2-to-1 that the Enzo patent was invalid for lack of written description of the claimed invention. The decision confirmed an earlier lower court ruling.